InsidersTradesSigma
Follow the CG인바이츠 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, CG인바이츠 has logged 100 reports. Market capitalisation: €59.2bn. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: 뉴레이크인바이츠투자. The full history is accessible without an account.
98
Insider Decl.
n/a
Thresholds
€613,429
60 ops.
Buy Volume
n/a
26 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,425 of 29,024 companies
10.0
score / 100
Value13
Quality7
FCF yld-36%
Earn yld-4.9%
EV/EBITDA·
ROE·
Gross mgn-7.1%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations100 total
Other
Other
KRXDART:20260630001123
2,074,192 sharesKRXDART:20260701000147
926,376 sharesKRXDART:20260130000681
104,400 sharesShareKRXDART:20260119000080
148,642 sharesKRXDART:20250605000164
189,135 sharesKRXDART:20250407003286
1,754,548 sharesKRXDART:20241230000379
25 of 100 declarations
About CG인바이츠
CG인바이츠 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.